The Pharmaletter

One To Watch

italfarmaco_company-1

Italfarmaco

A specialty pharmaceutical company engaged in the discovery, development, manufacturing and marketing of branded prescription and nonprescription products in more than 60 countries on five continents.

Italfarmaco Group’s research and development expertise is best demonstrated through its HDAC inhibitor development programs, addressing new therapeutic treatments of specialty and rare diseases.

Want to Update your Company's Profile?


More Italfarmaco news >